Following a comprehensive evaluation that includes both fundamental and technical analysis, as well as an in-depth assessment of prevailing investor sentiment and consultations with industry experts, it has become apparent that EYE is currently trading at a premium relative to its intrinsic value. Based on this analysis, I project that EYE will undergo a gradual correction towards its fair value, which I estimate to lie between $0.175 and $0.19. However, this price adjustment is unlikely to occur in a straightforward manner; rather, I anticipate a series of intermittent rallies and pullbacks as the stock price trends downwards towards these more sustainable levels.
Stonks92
CMS Proposes Major Increase in Reimbursement for Canaloplasty, page-390
-
- There are more pages in this discussion • 118 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
19.5¢ |
Change
0.005(2.63%) |
Mkt cap ! $44.66M | |||
| Open | High | Low | Value | Volume |
| 20.0¢ | 20.0¢ | 19.5¢ | $9.907K | 50.65K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 65104 | 19.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.0¢ | 51773 | 2 |
View Market Depth
| Last trade - 13.43pm 13/09/2024 (20 minute delay) ? |
| EYE (ASX) Chart |